Avi Goldberg
Partner at GreatPoint Ventures
New York, New York
Overview
Work Experience
Partner
2022 - Current
GreatPoint Ventures is an early-stage venture capital firm investing between $250k and $20m into Seed, A, and B rounds.
Member
2022
Board Observer
2024
Board Observer
2024
Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility.
Raised $100,400,038.00 from Ronovo Surgical, Mint Venture Partners, Tao Capital Partners, Cota Capital, ATEL Growth Capital, LRVHealth, Alumni Ventures, Rising Tide, Magnetar Capital and Hikma Ventures.
Board Observer
2024
Datalogz is a BI Ops platform that provides visibility into business intelligence environments.
Raised $7,089,999.00 from Trajectory Ventures, GreatPoint Ventures, Graphene Ventures, Defined, Define Ventures, Squadra Ventures, Mana Ventures and Berkeley SkyDeck Fund.
Founder and Board Advisor at Dispatch (Vista Equity portfolio company)
2020
Founder and CEO
2013 - 2020
Dispatch is the operating system that empowers modern service experiences for the world’s largest service brands.
Raised $18,100,000.00 from Vista Equity Partners and GrandBanks Capital.
Co-Founder, Investor & Board Member
2019
Strategic Advisor
2021
Whetstone AI provides architectural, strategic, and implementation services to technology organizations of all sizes, focused on big data, AI, and automation. We help companies avoid the hype of AI and instead adopt a holistic data strategy involving both long-term IP and data asset creation as well as tactical, continuous value delivery through targeted data & AI applications.
Investor
2019
Assembly OSM delivers architecturally distinctive high-rise buildings through their innovative building systems.
Raised $38,000,000.00 from Stratus Ventures, RSE Ventures, Karman Ventures (fka Moving Capital), Gaingels, Manta Ray Ventures, Bessemer Venture Partners, Jefferies Financial Group, Tectonic Capital, Atento Capital and Signia Venture Partners.
Co-Founder and Board Member
2005 - 2016
Zafgen is an innovative, capital efficient company dedicated to addressing unmet needs of severely obese patients by bringing beloranib, a first-in-class novel medicine, to market.